LUKAS SCHEIBLER Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for LUKAS SCHEIBLER.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of LUKAS SCHEIBLER. LUKAS SCHEIBLER is a EVP of Research & Development in ACUCELA INC. ($M??????) and a EVP of Translational Medicine in ACUCELA INC. ($M??????) and a CHIEF INNOVATION OFFICER in Apellis Pharmaceuticals, Inc. ($APLS) and a See Remarks in Apellis Pharmaceuticals, Inc. ($APLS).
Address: C/O ACUCELA INC. 1301 SECOND AVE., SUITE 4200 SEATTLE 98101 WA
Companies in which LUKAS SCHEIBLER is an Insider
Apellis Pharmaceuticals, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of LUKAS SCHEIBLER: CHIEF INNOVATION OFFICER, See Remarks
Holdings: 29,290 shares
Latest Transaction: Feb 11 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
KUBOTA PHARMACEUTICAL HOLDINGS CO LTD
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of LUKAS SCHEIBLER: EVP of Research & Development, EVP of Translational Medicine
Holdings: 12,358 shares
Latest Transaction: Jul 18 2017
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of LUKAS SCHEIBLER
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 11 2021 | APLS | Apellis Pharmaceut ... | SCHEIBLER LUKAS | CHIEF INNOVATION OF ... | Payment of Exercise | F | 47.72 | 680 | 32,450 | 29,290 | 30 K to 29.3 K (-2.27 %) |
| Feb 01 2021 | APLS | Apellis Pharmaceut ... | SCHEIBLER LUKAS | CHIEF INNOVATION OF ... | Option Exercise | A | 44.90 | 11,250 | 505,125 | 11,250 | |
| Feb 01 2021 | APLS | Apellis Pharmaceut ... | SCHEIBLER LUKAS | CHIEF INNOVATION OF ... | Option Exercise | A | 44.90 | 45,000 | 2,020,500 | 45,000 | |
| Feb 01 2021 | APLS | Apellis Pharmaceut ... | SCHEIBLER LUKAS | CHIEF INNOVATION OF ... | Grant | A | 0.00 | 1,875 | 0 | 29,970 | 28.1 K to 30 K (+6.67 %) |
| Feb 01 2021 | APLS | Apellis Pharmaceut ... | SCHEIBLER LUKAS | CHIEF INNOVATION OF ... | Grant | A | 0.00 | 7,500 | 0 | 28,095 | 20.6 K to 28.1 K (+36.42 %) |
| Feb 01 2021 | APLS | Apellis Pharmaceut ... | SCHEIBLER LUKAS | CHIEF INNOVATION OF ... | Option Exercise | A | 44.90 | 11,250 | 505,125 | 11,250 | |
| Feb 01 2021 | APLS | Apellis Pharmaceut ... | SCHEIBLER LUKAS | CHIEF INNOVATION OF ... | Option Exercise | A | 44.90 | 45,000 | 2,020,500 | 45,000 |